Established in 2022, the IHT Lab employees currently 30 members, mostly biomedical engineers and scientists, with strong background on Artificial Intelligence, Internet of Things, Tissue Engineering, biomedical signal/image processing and Robotics focusing on Global Health Challenges including chronic disease management, rare diseases, cancers, rare cancers, biomedical engineering for cardiovascular diseases (CVD) and rare CVD. The lab is focused on deploying impactful solutions for improving quality of life and wellbeing in high-income as well as in Low/Middle income countries (LMIC), focusing on limited resource settings, which are common in both settings.
The lab has just launched an Observatory on Science and Technology for Global Health, which will focus particularly on sciences and technologies for prevention, preparedness, response, mitigation, control and restore in response to global health challenges.
- The lab is a proactive member of large EU Consortia for different National and International ongoing projects, such as ODIN, EPoCA, ENKORE, GRACE, Afya Moja, AI4RareDisease, and FIT4MEDROB.
- Finally, the lab is supports the World Health Organization in producing guidelines and policies on medical devices, such as the WHO Guideline on Medical Devices donation, published in 2024, and WHO Guidance for National Policies for medical devices, which is going to be published in Q1 of 2025: here the 2011 edition, the new one written by the lab is under revision at the WHO and will be available soon.